Carmat S.A. (ALCAR.PA)

PAR Healthcare Medical - Devices

Carmat S.A. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Vélizy-Villacoublay, FR. The stock last traded at $0.10, up 0.00% on the session, giving a market capitalisation of $6.4M. Its beta of 1.02 implies it has historically moved more than the broad market.

Carmat SA specializes in engineering and creating a full artificial heart, specifically designed for individuals worldwide who are afflicted with severe, late-stage biventricular heart failure. The company commenced operations in 2008 and is based in Vélizy-Villacoublay, France.

Carmat S.A. is most often compared with the following Healthcare names: